The intracellular signalosome of PD-L1 in cancer cells | Signal Transduction and Targeted Therapy
Release the B7.1! Anti-PD-L1 breaks PD-L1's grip
PD−L1 immunostaining: what pathologists need to know | Diagnostic Pathology | Full Text
Cancer: anti-PD-1 / PD-L1 antibodies, new solutions for immunotherapy
Mechanism of action of PD-1 and PD-L1 inhibitors. The programmed cell... | Download Scientific Diagram
Frontiers | PD-1/PD-L1 Based Combinational Cancer Therapy: Icing on the Cake
Cells | Free Full-Text | The Importance of Exosomal PD-L1 in Cancer Progression and Its Potential as a Therapeutic Target
PD-1
PDL1 e immunoterapici | L'immunologo risponde | alcase.eu
IJMS | Free Full-Text | Navigating through the PD-1/PDL-1 Landscape: A Systematic Review and Meta-Analysis of Clinical Outcomes in Hepatocellular Carcinoma and Their Influence on Immunotherapy and Tumor Microenvironment
Identification and Validation of a PD-L1 Binding Peptide for Determination of PDL1 Expression in Tumors | Scientific Reports
Peptide for Determination of PDL1 Expression in Tumors | LifeTein Peptide Blog
PD-1 & PD-L1 Inhibitors - Assay Genie
Biomedicines | Free Full-Text | PD-1/PD-L1 Pathway: A Therapeutic Target in CD30+ Large Cell Lymphomas
Mechanistic insight of predictive biomarkers for antitumor PD‑1/PD‑L1 blockade: A paradigm shift towards immunome evaluation (Review)
Frontiers | Resistance Mechanisms of Anti-PD1/PDL1 Therapy in Solid Tumors
The roles of PD-1/PD-L1 in the prognosis and immunotherapy of prostate cancer - ScienceDirect
PD-1/PD-L1 inhibitors treatment in lung cance | EurekAlert!
The importance of exosomal PDL1 in tumour immune evasion | Nature Reviews Immunology